Richard Fedorak

551 total citations
8 papers, 48 citations indexed

About

Richard Fedorak is a scholar working on Surgery, Epidemiology and Genetics. According to data from OpenAlex, Richard Fedorak has authored 8 papers receiving a total of 48 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Surgery, 3 papers in Epidemiology and 3 papers in Genetics. Recurrent topics in Richard Fedorak's work include Inflammatory Bowel Disease (3 papers), Gallbladder and Bile Duct Disorders (2 papers) and Pancreatitis Pathology and Treatment (2 papers). Richard Fedorak is often cited by papers focused on Inflammatory Bowel Disease (3 papers), Gallbladder and Bile Duct Disorders (2 papers) and Pancreatitis Pathology and Treatment (2 papers). Richard Fedorak collaborates with scholars based in Canada, Belgium and United Kingdom. Richard Fedorak's co-authors include Rachel Fournier, Trevor van Mierlo, Levinus A. Dieleman, Naoki Chiba, Brian G. Feagan, Robert Enns, Denis Petrunia, Jody Backer, Des Leddin and Karen Madsen and has published in prestigious journals such as Gastroenterology, Hepatology and The American Journal of Gastroenterology.

In The Last Decade

Richard Fedorak

7 papers receiving 45 citations

Peers

Richard Fedorak

GENET

EPIDE

SURGE

GHP

MB

Jessica Amankwah Osei Canada

Pilar Robledo Spain

Julia Gorospe Canada

Geun-Yong Kwon South Korea

Ashkan Rezazadeh Ardabili Netherlands

Akihiko Kawase Japan

Gabriel Bedoya‐Berrío Colombia

J Martínez-Cadilla Spain

Danya Muilwijk Netherlands

Sezin Aydemir Türkiye

Jessica Amankwah Osei Canada

Richard Fedorak

36 ×1.3

GENET

32 ×1.4

EPIDE

17 ×1.1

SURGE

9 ×0.8

GHP

2 ×0.3

MB

Citations per year, relative to Richard Fedorak Richard Fedorak (= 1×) peers Jessica Amankwah Osei

Countries citing papers authored by Richard Fedorak

Since Specialization

Citations

This map shows the geographic impact of Richard Fedorak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard Fedorak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard Fedorak more than expected).

Fields of papers citing papers by Richard Fedorak

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard Fedorak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard Fedorak. The network helps show where Richard Fedorak may publish in the future.

Co-authorship network of co-authors of Richard Fedorak

This figure shows the co-authorship network connecting the top 25 collaborators of Richard Fedorak. A scholar is included among the top collaborators of Richard Fedorak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard Fedorak. Richard Fedorak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Mierlo, Trevor van, Rachel Fournier, & Richard Fedorak. (2015). Don’t Forget the Doctor: Gastroenterologists’ Preferences on the Development of mHealth Tools for Inflammatory Bowel Disease. JMIR mhealth and uhealth. 3(1). e5–e5. 13 indexed citations

2.

Gane, Edward, Éric Sicard, Stuart C. Gordon, et al.. (2013). Safety and Pharmacodynamics of Oral TLR-7 agonist GS-9620 in patients with Chronic Hepatitis B. Hepatology. 58. 4 indexed citations

3.

Huang, Vivian, Karen I. Kroeker, Karen J. Goodman, Levinus A. Dieleman, & Richard Fedorak. (2013). P409 Physician knowledge of reproductive issues in inflammatory bowel disease is highly variable. Journal of Crohn s and Colitis. 7. S173–S174. 1 indexed citations

4.

Hanauer, Stephen B., Jean–Frédéric Colombel, Brian G. Feagan, et al.. (2012). Vedolizumab Maintenance Therapy for Crohnʼs Disease: Results of GEMINI II, a Randomized, Placebo-Controlled, Double-Blind, Multi-center Phase 3 Trial. The American Journal of Gastroenterology. 107. S620–S621. 2 indexed citations

5.

Wong, Winnie, et al.. (2008). Prevalence and Outcome of Upper Gastrointestinal Bleeding Post-coronary Artery Bypass Graft.. PubMed. 2(1). 69–76. 3 indexed citations

6.

Romagnuolo, Joseph, Robert J. Hilsden, Gurpal Sandha, et al.. (2008). Allopurinol to Prevent Pancreatitis After Endoscopic Retrograde Cholangiopancreatography (ERCP): A Randomized Placebo-Controlled Trial. Gastrointestinal Endoscopy. 67(5). AB328–AB328. 1 indexed citations

7.

Madsen, Karen, Jody Backer, Des Leddin, et al.. (2008). M1207 A Randomized Controlled Trial of VSL#3 for the Prevention of Endoscopic Recurrence Following Surgery for Crohn's Disease. Gastroenterology. 134(4). A–361. 23 indexed citations

8.

Romagnuolo, Joseph, et al.. (2005). Allopurinol to Prevent Post-ERCP Pancreatitis: Blind Interim Analysis of a Randomized Placebo-Controlled Trial. Gastrointestinal Endoscopy. 61(5). AB195–AB195. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact